Biomaterials Market by Type [Metallic (Gold, Magnesium), Ceramic (Aluminum Oxide, Carbon), Polymer (Polyethylene, Polyester), Natural (Hyaluronic acid, Collagen, Gelatin)], Application (Orthopedic, Dental, CVD, Ophthalmology) - Global Forecast to 2030

icon1
USD 68.93 BN
MARKET SIZE, 2030
icon2
CAGR 7.3%
(2025-2030)
icon3
665
REPORT PAGES
icon4
908
MARKET TABLES

OVERVIEW

biomaterials Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global biomaterials market, valued at USD 45.15 billion in 2024, stood at USD 48.36 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of USD 68.93 billion by the end of the period. Biomaterials are specially crafted materials designed to interact safely with biological systems for medical applications. These substances are engineered for biocompatibility with living tissues and support diverse uses, including implants, prosthetics, drug delivery systems, and tissue engineering.

KEY TAKEAWAYS

  • BY REGION
    The Asia Pacific is the fastest-growing regional segment with a CAGR of 7.8% during the forecast period.
  • BY TYPE
    By type, metallic biomaterials are projected to show the highest CAGR of 7.6% between 2025 and 2030.
  • BY APPLICATION
    By application, the orthopedic segment is expected to dominate the global biomaterials market in 2024 with a CAGR of 34.9%.
  • COMPETITIVE LANDSCAPE
    BASF SE, Celanese corporation, Carpenter technology, were identified as some of the star players in the global biomaterials market, given their strong market share and product footprint.
  • COMPETITIVE LANDSCAPE
    Collagen Solution and Jellatech have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The global biomaterials market is expanding rapidly, driven by the surge in precision-medicine programs and the routine use of biomarker-guided tests in oncology, cardiology, and other complex diseases.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The biomaterials market is emerging with innovative developments and smart applications of technology, processing, and regulations that work in perfect synchrony with precision medicine, tissue-engineered therapies, and complex biologic treatments. The large and ever-expanding patient base across the global healthcare systems, fighting cancer, cardiovascular diseases, musculoskeletal diseases requiring orthopedic interventions, and neurological disorders, is driving the need for superior biomaterials with a proven track record of reliable and durable clinical outcomes through innovative biomaterials in the form of implants, scaffolds, and drug-delivery devices. Clinically proven and automation-friendly products such as bioresorbable polymers, bioactive ceramics, and collagen bioengineered scaffolds are also gaining increasing acceptances, as they enhance procedures, help with personalized and minimally invasive procedures aligned with the regulator and payer communities in developed regions such as Asia Pacific and North America.

biomaterials Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising advancements in smart, biocompatible, and 3D-printed biomaterials
  • Advancements in healthcare facilities and systems
RESTRAINTS
Impact
Level
  • High development and production costs associated with advanced biomaterials
OPPORTUNITIES
Impact
Level
  • Expanding applications in tissue engineering and regenerative medicine
CHALLENGES
Impact
Level
  • Concerns related to biocompatibility, safety, and adverse immune responses

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising advancements in smart, biocompatible, and 3D-printed biomaterials

Innovations in smart biocompatible and 3D-printed biomaterials are driving market growth, yielding improved clinical outcomes through bioresorbable polymers, surface-modified implants, and expanded applications.

Restraint: High development and production costs associated with advanced biomaterials

High development and production costs for advanced biomaterials, along with complex regulatory approvals, limit scalability and market penetration.

Opportunity: Expanding applications in tissue engineering and regenerative medicine

Biomaterials applications in tissue engineering, regenerative medicine, and personalized therapy represent a significant area of growth potential amidst the rising prevalence of chronic diseases.

Challenge: Concerns related to biocompatibility, safety, and adverse immune responses

Biocompatibility issues, immune reactions, and variability in long-term performance pose ongoing hurdles to the widespread adoption.

BIOMATERIALS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Produces biodegradable lactic acid-based biomaterials (PLA and related polymers) used in controlled drug delivery, tissue regeneration, and resorbable implants. Enables biodegradable implant solutions that support tissue healing and reduce long-term foreign body presence.
Manufactures specialty biomaterial polymers for applications in tissue engineering, drug delivery systems, and medical devices. Enhances material performance with tailored degradation rates, mechanical strength, and biocompatibility for varied clinical needs.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The global biomaterials market is a highly interconnected market where material researchers, device makers, biotechnology and medical technology firms, research institutions, and physicians work together for the introduction of novel solutions based on biomaterials in medicine. Manufacturers, along with specialty material suppliers, offer high-performance polymer, metal, ceramic, and natural biomaterials. Contract research organizations, contract development and manufacturing organizations, and academic research facilities assist in preclinical studies, clinical studies, and commercialization for implants, drug delivery systems, and regenerative medicine based on biomaterials. European medical facilities, reference, and reimbursement systems translate clinical confirmations for biomaterials into practical, innovative, precision medicine for Europe on a daily basis through their normal operations.

biomaterials Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

biomaterials Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Global Biomaterials Market, By Type

In 2024, metallic biomaterials dominated due to the wide use of metals in the manufacturing of medical devices for cardiovascular, dental, and orthopedic applications.

Global Biomaterials Market, By Application

In 2024, the orthopedic segment accounted for the largest share of the biomaterials market. Its market leadership can be attributed to the increasing prevalence of orthopedic conditions, such as osteoarthritis, osteoporosis, and musculoskeletal injuries.

REGION

APAC to be fastest-growing region in market during forecast period

In 2024, the APAC region emerged as the fastest-growing in the global biomaterials market, driven by its dense network of academic medical centers, specialized surgical hospitals, and dynamic life-science innovation hubs. A robust pipeline of orthopedic, cardiovascular, dental, and regenerative therapies, paired with significant investments in personalized medicine and extensive clinical trials, fuels this surge.

biomaterials Region

BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX

In the global biomaterials market, BASF leads as the star player, leading the polymer segment with its extensive lineup of medical-grade plastics and superabsorbent materials that hospitals and device OEMs worldwide trust for wound-care dressings, surgical pads, and reliable components in drug-delivery and surgical instruments. Mitsubishi Chemical emerges as a rising leader, building momentum via its specialty metal and biomaterial units that deliver precision alloys, implantable textiles, and polymer scaffolds, enabling MedTech and biopharma partners across key regions to pioneer next-gen cardiovascular, orthopedic, and cell-therapy devices.

biomaterials Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 45.15 Billion
Market Forecast in 2030 (Value) USD 68.93 Billion
Growth Rate CAGR of 7.3 % from 2025-2030
Years Considered 2023-2030
Base Year 2024
Forecast Period 2025-2030
Units Considered Value (USD Million/Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Type:
    • Metallic Biomaterials
    • Polymeric Biomaterials
    • Ceramic Biomaterials
    • Natural Biomaterials
  • By Application:
    • Orthopedic
    • Cardiovascular
    • Dental
    • Plastic Surgery
    • Urinary
    • Wound Healing
    • Tissue Engineering
    • Ophthalmology
    • Neurological/Central Nervous System
    • Other Applications
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Related Segment & Geographic Reports Orthopedic Biomaterials Market
North America Biomaterials Market
Europe Biomaterials Market
Asia Pacific Biomaterials Market
Polymeric Biomaterials Market

WHAT IS IN IT FOR YOU: BIOMATERIALS MARKET: REPORT CONTENT GUIDE

biomaterials Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Benchmarking end-user preferences for biomaterial types and applications Mapped how surgeons, interventional cardiologists, and dental specialists prioritize metallic, polymeric, ceramic, and natural biomaterials across orthopedic, cardiovascular, dental, and wound-healing procedures, including trade-offs in handling, longevity, and reimbursement Informs portfolio strategy and clinical-education efforts by showing which biomaterial families are gaining share in each specialty, enabling commercial teams to target the right KOLs, procedures, and indication expansions with differentiated value messages
Identifying outsourcing and partnership opportunities for biomaterial-based device development Mapped leading biomaterials-focused CDMOs and contract manufacturers and OEMs with polymer synthesis, implant forming, sterile packaging, and regulatory-compliant scale-up, highlighting examples such as Corbion, Life Science Outsourcing, Evonik, Regenity, and specialized bioresorbable-device developers. Helps clients prioritize high-value partners for co-development and manufacturing, shortens time-to-market for new implants and scaffolds, and reduces capex by leveraging existing GMP infrastructure purpose-built for advanced biomaterials

RECENT DEVELOPMENTS

  • March 2023 : Celanese Corporation and Alessa Therapeutics have entered a collaboration to combine Alessa’s sustained, localized drug-delivery expertise with Celanese’s VitalDose EVA platform to develop a localized, sustained-release oncology drug-delivery system aimed at reducing systemic side effects for cancer patients
  • April 2023 : Celanese Corporation signed an agreement with Glaukos to supply its VitalDose drug-delivery platform as a key component of Glaukos’ iDose TR, a micro-invasive intraocular implant designed to provide long-duration glaucoma therapy by continuously reducing intraocular pressure in patients with open-angle glaucoma or ocular hypertension

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
 
4
MARKET OVERVIEW
Explains the evolving landscape through demand-side drivers, supply-side constraints, and opportunity hotspots.
 
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNTIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
5
INDUSTRY TRENDS
Covers the key developments, trend analysis, and actionable insights to support strategic planning and positioning.
 
 
 
 
 
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
5.2.3
TRENDS IN THE GLOBAL BIOMATERIALS MARKET
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022-2024)
 
 
 
 
 
5.5.2
AVERAGE SELLING PRICE TREND, BY REGION (2024)
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
5.6.1
IMPORT SCENARIO (HS CODE 7221)
 
 
 
 
 
5.6.2
EXPORT SCENARIO (HS CODE 7221)
 
 
 
 
5.7
KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
5.9
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
 
5.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
 
 
 
 
5.10
IMPACT OF 2025 US TARIFF – GLOBAL BIOMATERIALS MARKET
 
 
 
 
 
 
 
5.10.2
INTRODUCTION
 
 
 
 
 
5.10.2
KEY TARIFF RATES
 
 
 
 
 
5.10.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
5.10.4
IMPACT ON COUNTRIES
 
 
 
 
 
 
5.12.4.1
US
 
 
 
 
 
5.12.4.2
CANADA
 
 
 
 
5.11.5
IMPACT ON END-USE INDUSTRIES
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
 
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
6.1.1
PRECISION TECHNOLOGY
 
 
 
 
 
6.1.2
BIOMIMETICS
 
 
 
 
6.2
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
6.2.1
3D BIOPRINTING
 
 
 
 
 
6.2.1
ELECTROSPINNING
 
 
 
 
6.3
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
6.4
PATENT ANALYSIS
 
 
 
 
 
 
6.5
FUTURE APPLICATIONS
 
 
 
 
 
6.6
IMPACT OF AI/GEN AI ON GLOBAL BIOMATERIALS MARKET
 
 
 
 
 
 
 
6.6.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
6.6.2
CASE STUDIES OF AI IMPLEMENTATION IN THE GLOBAL BIOMATERIALS MARKET
 
 
 
 
 
6.6.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
6.6.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE GLOBAL BIOMATERIALS MARKET
 
 
 
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
 
 
 
 
 
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
 
 
 
 
 
7.3
CERTIFICATIONS, LABELING, ECO-STANDARDS
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
9
GLOBAL BIOMATERIALS MARKET, BY TYPE, 2023-2030 (USD MILLION)
 
 
 
 
 
 
COMPARATIVE ASSESSMENT OF KEY PRODUCTS, THEIR MARKET POTENTIAL, AND REVENUE TRENDS
 
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
 
9.2
METALLIC BIOMATERIALS
 
 
 
 
 
 
9.2.1
STAINLESS STEEL
 
 
 
 
 
9.2.2
TITANIUM & TITANIUM ALLOYS
 
 
 
 
 
9.2.3
COBALT-CHROME ALLOYS
 
 
 
 
 
9.2.4
SILVER
 
 
 
 
 
9.2.5
GOLD
 
 
 
 
 
9.2.6
MAGNESIUM
 
 
 
 
 
9.2.7
OTHER METALLIC BIOMATERIALS
 
 
 
 
9.3
POLYMERIC BIOMATERIALS
 
 
 
 
 
 
9.3.1
POLYMETHYLMETHACRYLATE (PMMA)
 
 
 
 
 
9.3.2
POLYETHYLENE
 
 
 
 
 
9.3.3
POLYESTER
 
 
 
 
 
9.3.4
POLYVINYLCHLORIDE
 
 
 
 
 
9.3.5
SILICONE RUBBER
 
 
 
 
 
9.3.6
NYLON
 
 
 
 
 
9.3.7
POLYETHERETHERKETONE (PEEK)
 
 
 
 
 
9.3.8
OTHER POLYMERIC BIOMATERIALS
 
 
 
 
9.4
CERAMIC BIOMATERIALS
 
 
 
 
 
 
9.4.1
CALCIUM PHOSPHATE
 
 
 
 
 
9.4.2
ZIRCONIA
 
 
 
 
 
9.4.3
ALUMINUM OXIDE
 
 
 
 
 
9.4.4
CALCIUM SULFATE
 
 
 
 
 
9.4.5
CARBON
 
 
 
 
 
9.4.6
GLASS
 
 
 
 
9.5
NATURAL BIOMATERIALS
 
 
 
 
 
 
9.5.1
HYALURONIC ACID
 
 
 
 
 
9.5.2
COLLAGEN
 
 
 
 
 
9.5.3
FIBRIN
 
 
 
 
 
9.5.4
CELLULOSE
 
 
 
 
 
9.5.5
CHITIN
 
 
 
 
 
9.5.6
ALGINATE
 
 
 
 
 
9.5.7
GELATIN
 
 
 
 
 
9.5.8
CHITOSAN
 
 
 
 
 
9.5.9
SILK
 
 
 
 
 
9.5.10
OTHER NATURAL BIOMATERIALS
 
 
 
11
GLOBAL BIOMATERIALS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
 
 
 
 
 
 
APPLICATION-WISE DEMAND POTENTIAL AND GROWTH PATHWAYS PHARMACEUTICAL FILTRATION ADOPTION IN DIVERSE INDUSTRIES
 
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
 
11.2
CARDIOVASCULAR
 
 
 
 
 
 
11.2.1
CATHETERS
 
 
 
 
 
11.2.2
STENTS
 
 
 
 
 
11.2.3
IMPLANTABLE CARDIAC DEFIBRILLATORS
 
 
 
 
 
11.2.4
PACEMAKERS
 
 
 
 
 
11.2.5
SENSORS
 
 
 
 
 
11.2.6
HEART VALVES
 
 
 
 
 
11.2.7
VASCULAR GRAFTS
 
 
 
 
 
11.2.8
GUIDEWIRES
 
 
 
 
 
11.2.9
OTHER PRODUCTS
 
 
 
 
11.3
ORTHOPEDIC
 
 
 
 
 
 
11.3.1
JOINT REPLACEMENT
 
 
 
 
 
 
11.3.1.1
KNEE REPLACEMENT
 
 
 
 
 
11.3.1.2
HIP REPLACEMENT
 
 
 
 
 
11.3.1.3
SHOULDER REPLACEMENTS
 
 
 
 
 
11.3.1.4
OTHER JOINT REPLACEMENT APPLICATIONS
 
 
 
 
11.3.2
SPINE SURGERIES
 
 
 
 
 
 
11.3.2.1
SPINAL FUSION
 
 
 
 
 
11.3.2.2
MINIMALLY INVASIVE FUSION
 
 
 
 
 
11.3.2.3
MOTION PRESERVATION & DYNAMIC STABILIZATION
 
 
 
 
 
 
11.3.2.3.1
PEDICLE-BASED ROD SYSTEMS
 
 
 
 
 
11.3.2.3.2
INTERSPINOUS SPACERS
 
 
 
 
 
11.3.2.3.3
ARTIFICIAL DISCS
 
 
 
11.3.3
BIORESORBABLE TISSUE FIXATION
 
 
 
 
 
 
11.3.3.1
SUTURE ANCHORS
 
 
 
 
 
11.3.3.2
INTERFERENCE SCREWS
 
 
 
 
 
11.3.3.3
MENISCAL REPAIR TACKS
 
 
 
 
 
11.3.3.4
MESHES
 
 
 
 
11.3.4
ORTHOBIOLOGICS
 
 
 
 
 
11.3.5
FRACTURE FIXATION
 
 
 
 
 
 
11.3.5.1
BONE PLATES
 
 
 
 
 
11.3.5.2
SCREWS
 
 
 
 
 
11.3.5.3
PINS
 
 
 
 
 
11.3.5.4
RODS
 
 
 
 
 
11.3.5.5
WIRES
 
 
 
11.4
OPHTHALMOLOGY
 
 
 
 
 
 
11.4.1
CONTACT LENSES
 
 
 
 
 
11.4.2
INTRAOCULAR LENSES
 
 
 
 
 
11.4.3
FUNCTIONAL REPLACEMENTS OF OCULAR TISSUES
 
 
 
 
 
11.4.4
SYNTHETIC CORNEAS
 
 
 
 
 
11.4.5
OTHER OPHTHALMOLOGY APPLICATIONS
 
 
 
 
11.5
DENTAL
 
 
 
 
 
 
11.5.1
DENTAL IMPLANTS
 
 
 
 
 
11.5.2
DENTAL BONE GRAFTS & SUBSTITUTES
 
 
 
 
 
11.5.3
DENTAL MEMBRANES
 
 
 
 
 
11.5.4
TISSUE REGENERATION MATERIALS
 
 
 
 
11.6
PLASTIC SURGERY
 
 
 
 
 
 
11.6.1
SOFT-TISSUE FILLERS
 
 
 
 
 
11.6.2
CRANIOFACIAL SURGERY
 
 
 
 
 
11.6.3
FACIAL WRINKLE TREATMENT
 
 
 
 
 
11.6.4
BIOENGINEERED SKINS
 
 
 
 
 
11.6.5
PERIPHERAL NERVE REPAIR
 
 
 
 
 
11.6.6
ACELLULAR DERMAL MATRICES
 
 
 
 
11.7
WOUND HEALING
 
 
 
 
 
 
11.7.1
WOUND CLOSURE DEVICES
 
 
 
 
 
 
11.7.1.1
SUTURES
 
 
 
 
 
11.7.1.2
STAPLES
 
 
 
 
11.7.2
INTERNAL TISSUE SEALANTS
 
 
 
 
 
11.7.3
SURGICAL HEMOSTATS
 
 
 
 
 
11.7.4
ADHESION BARRIERS
 
 
 
 
 
11.7.5
HERNIA MESHES
 
 
 
 
 
11.7.6
SKIN SUBSTITUTES
 
 
 
 
11.8
TISSUE ENGINEERING
 
 
 
 
 
 
11.8.1
SCAFFOLDS FOR BIOMATERIALS
 
 
 
 
 
11.8.2
NANOMATERIALS FOR BIOSENSING
 
 
 
 
 
11.8.3
TAILORING OF INORGANIC NANOPARTICLES
 
 
 
 
11.9
NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS
 
 
 
 
 
 
11.9.1
SHUNTING SYSTEMS
 
 
 
 
 
11.9.2
CORTICAL NEURAL PROSTHETICS
 
 
 
 
 
11.9.3
HYDROGEL SCAFFOLDS FOR CNS REPAIR
 
 
 
 
 
11.9.4
NEURAL STEM CELL ENCAPSULATION
 
 
 
 
11.10
URINARY APPLICATIONS
 
 
 
 
 
 
11.10.1
URINARY CATHETERS
 
 
 
 
 
11.10.2
URETHRAL STENTS
 
 
 
 
 
11.10.3
OTHERS
 
 
 
 
11.11
OTHER APPLICATIONS
 
 
 
 
 
 
11.11.1
DRUG DELIVERY SYSTEMS
 
 
 
 
 
11.11.2
GASTROINTESTINAL APPLICATIONS
 
 
 
 
 
11.11.3
BARIATRIC SURGERY
 
 
 
12
GLOBAL BIOMATERIALS MARKET, BY REGION, 2023-2030 (USD MILLION)
 
 
 
 
 
 
ASSESSMENT OF GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY GEOGRAPHIES AND COUNTRIES
 
 
 
 
 
 
12.1
INTRODUCTION
 
 
 
 
 
12.2
NORTH AMERICA
 
 
 
 
 
 
12.2.1
US
 
 
 
 
 
12.2.2
CANADA
 
 
 
 
 
12.2.3
MACROECONOMIC OUTLOOK OF NORTH AMERICA
 
 
 
 
12.3
EUROPE
 
 
 
 
 
 
12.3.1
GERMANY
 
 
 
 
 
12.3.2
UK
 
 
 
 
 
12.3.3
FRANCE
 
 
 
 
 
12.3.4
ITALY
 
 
 
 
 
12.3.5
SPAIN
 
 
 
 
 
12.3.6
REST OF EUROPE
 
 
 
 
 
12.3.7
MACROECONOMIC OUTLOOK OF EUROPE
 
 
 
 
12.4
ASIA PACIFIC
 
 
 
 
 
 
12.4.1
CHINA
 
 
 
 
 
12.4.2
JAPAN
 
 
 
 
 
12.4.3
INDIA
 
 
 
 
 
12.4.4
SOUTH KOREA
 
 
 
 
 
12.4.5
AUSTRALIA
 
 
 
 
 
12.4.6
REST OF ASIA PACIFIC
 
 
 
 
 
12.4.7
MACROECONOMIC OUTLOOK OF ASIA PACIFIC
 
 
 
 
12.5
LATIN AMERICA
 
 
 
 
 
 
12.5.1
BRAZIL
 
 
 
 
 
12.5.2
MEXICO
 
 
 
 
 
12.5.3
REST OF LATIN AMERICA
 
 
 
 
 
12.5.4
MACROECONOMIC OUTLOOK OF LATIN AMERICA
 
 
 
 
12.6
MIDDLE EAST
 
 
 
 
 
 
12.6.1
GCC
 
 
 
 
 
 
12.6.1.1
UAE
 
 
 
 
 
12.6.1.2
SAUDI ARABIA
 
 
 
 
 
12.6.1.3
REST OF GCC
 
 
 
 
12.6.2
REST OF MIDDLE EAST
 
 
 
 
 
12.6.3
MACROECONOMIC OUTLOOK OF MIDDLE EAST
 
 
 
 
12.7
AFRICA
 
 
 
 
 
 
12.7.1
MACROECONOMIC OUTLOOK OF AFRICA
 
 
 
13
COMPETITIVE LANDSCAPE
 
 
 
 
 
 
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
 
 
 
 
 
 
 
13.1
INTRODUCTION
 
 
 
 
 
13.2
KEY PLAYERS STRATEGY/ RIGHT TO WIN
 
 
 
 
 
13.3
REVENUE ANALYSIS, 2022-2024
 
 
 
 
 
 
13.4
MARKET SHARE ANALYSIS,
 
 
 
 
 
 
13.5
COMPANY EVALUATION MATRIX: KEY PLAYERS
 
 
 
 
 
 
 
13.5.1
STARS
 
 
 
 
 
13.5.2
EMERGING LEADERS
 
 
 
 
 
13.5.3
PERVASIVE PLAYERS
 
 
 
 
 
13.5.4
PARTICIPANTS
 
 
 
 
 
13.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
 
13.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
13.5.5.2
REGION FOOTPRINT
 
 
 
 
 
13.5.5.3
PRODUCT FOOTPRINT
 
 
 
 
 
13.5.5.4
STERILITY TYPE FOOTPRINT
 
 
 
 
 
13.5.5.5
APPLICATION FOOTPRINT
 
 
 
13.6
COMPANY EVALUATION MATRIX: START-UPS/SMES,
 
 
 
 
 
 
 
13.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
13.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
13.6.3
DYNAMIC COMPANIES
 
 
 
 
 
13.6.4
STARTING BLOCKS
 
 
 
 
 
13.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
 
 
 
 
 
 
13.6.5.1
DETAILED LIST OF KEY STARTUPS/ SMES
 
 
 
 
 
13.6.5.2
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
 
 
 
13.7
COMPETITIVE SCENARIO
 
 
 
 
 
 
13.7.1
PRODUCT LAUNCHES
 
 
 
 
 
13.7.2
DEALS
 
 
 
 
 
13.7.3
OTHER DEVELOPMENTS
 
 
 
 
13.8
BRAND/ PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
 
13.9
VALUATION AND FINANCIAL METRICS
 
 
 
 
14
COMPANY PROFILES
 
 
 
 
 
 
14.1
KEY COMPANIES
 
 
 
 
 
 
14.1.1
BASF SE
 
 
 
 
 
14.1.2
COVESTRO AG
 
 
 
 
 
14.1.3
CELANESE CORPORATION
 
 
 
 
 
14.1.4
CARPENTER TECHNOLOGY CORPORATION.
 
 
 
 
 
14.1.5
EVONIK INDUSTRIES AG
 
 
 
 
 
14.1.6
DSM
 
 
 
 
 
14.1.7
CORBION NV
 
 
 
 
 
14.1.8
VICTREX PLC
 
 
 
 
 
14.1.9
CERAMTEC GMBH
 
 
 
 
 
14.1.10
MITSUBISHI CHEMICAL CORPORATION
 
 
 
 
 
14.1.11
COORSTEK INC.
 
 
 
 
 
14.1.12
BERKELEY ADVANCED BIOMATERIALS
 
 
 
 
 
14.1.13
CAM BIOCERAMICS B.V
 
 
 
 
 
14.1.14
ZEUS COMPANY INC
 
 
 
 
 
14.1.15
AMETEK INC
 
 
 
 
14.16
GELITA AG
 
 
 
 
 
14.2
OTHER PLAYERS
 
 
 
 
 
 
14.2.1
COLLAGEN SOLUTIONS LLC
 
 
 
 
 
14.2.2
BIOCOMPOSITES
 
 
 
 
 
14.2.3
NOBLE BIOMATERIALS, INC
 
 
 
 
 
14.2.4
REGENITY
 
 
 
 
 
14.2.5
KURARAY CO., LTD
 
 
 
 
 
14.2.6
SOLESIS
 
 
 
 
 
14.2.7
INSTITUT STRAUMANN AG
 
 
 
 
 
14.2.8
FOSTER CORPORATION
 
 
 
 
 
14.2.9
CDI PRODUCTS
 
 
 
15
RESEARCH METHODOLOGY
 
 
 
 
 
 
15.1
RESEARCH DATA
 
 
 
 
 
 
15.1.1
SECONDARY DATA
 
 
 
 
 
 
15.1.1.1
KEY SOURCES OF SECONDARY DATA
 
 
 
 
 
15.1.1.2
KEY OBJECTIVES OF SECONDARY DATA
 
 
 
 
15.1.2
PRIMARY DATA
 
 
 
 
 
 
15.1.2.1
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
15.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
 
 
 
15.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
15.2.1
GLOBAL BIOMATERIALS MARKET SIZE ESTIMATION
 
 
 
 
 
 
15.2.1.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
 
 
 
 
 
15.2.1.2
MNM REPOSITORY ANALYSIS
 
 
 
 
 
15.2.1.3
SECONDARY ANALYSIS
 
 
 
 
 
15.2.1.4
PRIMARY RESEARCH
 
 
 
 
 
 
15.2.1.4.1
INSIGHTS FROM PRIMARY EXPERTS
 
 
15.3
MARKET GROWTH RATE PROJECTIONS
 
 
 
 
 
15.4
DATA TRIANGULATION
 
 
 
 
 
15.6
RESEARCH ASSUMPTIONS
 
 
 
 
 
15.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
 
16
APPENDIX
 
 
 
 
 
 
16.1
DISCUSSION GUIDE
 
 
 
 
 
16.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
16.3
AVAILABLE CUSTOMIZATIONS
 
 
 
 
 
16.4
RELATED REPORTS
 
 
 
 
 
16.5
AUTHOR DETAILS
 
 
 
 

Methodology

This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyse the global Biomaterials market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the Global Biomaterials market. The secondary sources used for this study includes US Food and Drug Administration (USFDA), European Medicines Agency (EMA), National Institutes of Health (NIH), National Institute of Standards and Technology (NIST), European Commission (EC), Centers for Disease Control and Prevention (CDC), National Science Foundation (NSF), World Health Organization (WHO), Journal of Biomedical Nanotechnology, Journal of Materials Science, Materials Science and Engineering, Journal of Biomedical Materials Research, Biomedical Engineering Society (BMES), American Society for Testing and Materials (ASTM) International, Society for Biomaterials (SFB), European Society for Biomaterials (ESB); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Following an initial assessment of the global biomaterials market landscape through secondary research, comprehensive primary research was undertaken. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from pharmaceutical and biotechnology firms, CROs, CMOs, and academic and research institutions. Additionally, interviews were held with key supply-side participants, such as C-suite and senior executives, product managers, and marketing and sales leaders from prominent manufacturers, distributors, and channel partners. The research covered six major geographical regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while 30% involved demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and telephonic discussions to understand the market dynamics comprehensively.

The following is a breakdown of the primary respondents:

Biomaterials Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both bottom-up and top-down approaches were used to estimate and validate the total size of the Global Biomaterials market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • A list of the major global players operating in the Biomaterials market was generated.
  • The revenues generated from their Biomaterials product have been determined through annual reports and secondary sources (including paid databases)
  • The products were mapped according to the segments of the market. Percentage shares and splits were determined based on the revenue contributed to each segment. This was verified using secondary sources and by industry experts.
  • All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.

Biomaterials Market : Top-Down and Bottom-Up Approach

Biomaterials Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Biomaterials refer to substances that have been engineered to interact with biological systems for medical purposes. These materials are designed to be compatible with living tissues and can be used in various medical applications, such as implants, prosthetics, drug delivery systems, and tissue engineering.

Key Stakeholders

  • Biomaterial product manufacturing companies
  • Healthcare service providers (including hospitals & specialty clinics)
  • National and regional research boards and organizations
  • Research & development companies
  • Clinical research organizations (CROs)
  • Healthcare technology companies
  • Biotechnology companies
  • Research laboratories & academic institutes
  • Market research & consulting firms
  • Regulatory bodies

Report Objectives

  • To define, describe, and forecast the Global Biomaterials market based on type and application.
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the Biomaterials market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments concerning six main regions—North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa
  • To profile the key players in the global Biomaterials market and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as product approvals and launches, expansions, agreements, and collaborations in the Biomaterials market
  • To benchmark players within the Biomaterials market using the company evaluation matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to three).

Geographical Analysis

  • A further breakdown of the Rest of Asia Pacific Biomaterials market into countries
  • A further breakdown of the Rest of European Biomaterials market into countries
  • A further breakdown of the Rest of Latin American Biomaterials market into countries

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Biomaterials Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Biomaterials Market

Joshua

Oct, 2022

What are the recent developments in the Global Biomaterials Market?.

Alexander

Oct, 2022

Which factors are being the game changer in the global growth of Biomaterials Market?.

James

Oct, 2022

Which of the geographical segment holds the major share of the Biomaterials Market?.

Matthew

Jun, 2026

After reviewing the Biomaterials Market dynamics alongside the wound care applications covered in the report, I found the analysis useful for understanding how advanced polymers and regenerative materials are influencing product development strategies across healthcare companies..

Anthony

Jun, 2026

I went through the report to assess long-term commercial opportunities in the Biomaterials Market, and the segmentation around chronic wound management and bioactive dressings gave me a clearer perspective on future investment priorities..

Mark

Jun, 2026

The report helped me better understand how the Biomaterials Market is evolving within wound care manufacturing, especially regarding material compatibility, innovation trends, and the growing demand for cost-effective therapeutic solutions..

bottom banner
DMCA.com Protection Status